CVE-2022-37461Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdi…
Updated under an hour ago ()
Does this affect you?
It affects canon medical_vitrea_view. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 1.10%, higher than 65% of scored CVEs.
Do this next
Free account, 1 product
Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3) offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.
- CVSS
- 6.1 MEDIUM (v3.1, CISA ADP)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
- Weakness (CWE)
- CWE-79
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 1.10% (percentile 65)
- Assigned by
- mitre
- NVD analysis
- Modified
- Record last updated
- May 20, 2025
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
canon medical_vitrea_view canon:medical_vitrea_view | from 7.0 before 7.7.6 | NVD |
References
- https://www.vitalimages.com/vitrea-vision/vitrea-view/x-refsource-misc, product, vendor-advisory
- https://www.trustwave.com/en-us/resources/security-resources/security-advisories/?fid=30693x-refsource-misc, exploit, third-party-advisory
- https://www.vitalimages.com/customer-success-support-program/vital-images-software-security-updates/x-refsource-confirm, vendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.